Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
Titel:
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
Auteur:
Mosenzon, Ofri Wiviott, Stephen D Cahn, Avivit Rozenberg, Aliza Yanuv, Ilan Goodrich, Erica L Murphy, Sabina A Heerspink, Hiddo J L Zelniker, Thomas A Dwyer, Jamie P Bhatt, Deepak L Leiter, Lawrence A McGuire, Darren K Wilding, John P H Kato, Eri T Gause-Nilsson, Ingrid A M Fredriksson, Martin Johansson, Peter A Langkilde, Anna Maria Sabatine, Marc S Raz, Itamar